1naresh2naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [cfc17225-7423-4495-9f03-4447dced4bc2] => Array ( [runtime-id] => cfc17225-7423-4495-9f03-4447dced4bc2 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [fe71fed1-2353-40fb-b04e-ef04711ea2af] => Array ( [runtime-id] => fe71fed1-2353-40fb-b04e-ef04711ea2af [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;eda486afbcddb6dd9e7e84514b6d4a77295f906f ) ) ) 1naresh2nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [cfc17225-7423-4495-9f03-4447dced4bc2] => Array ( [runtime-id] => cfc17225-7423-4495-9f03-4447dced4bc2 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [fe71fed1-2353-40fb-b04e-ef04711ea2af] => Array ( [runtime-id] => fe71fed1-2353-40fb-b04e-ef04711ea2af [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;eda486afbcddb6dd9e7e84514b6d4a77295f906f ) ) )Clinical findings
Finding Case (No.) 1 2 3 4 5 6 Sex/age (mo) M/5 M/39 M/5 F/2.5 F/48 M/5 Symptom duration 3 wk 1 mo 2 mo 2.5 mo 2 mo 0 Increasing head circumference Y N N Y N N Seizures N Y Y N N N Increased ICP Y N N N Y N Other symptoms Skull deformation . . . . . . . . . Visual field . . . Treatment Total excision Total excision Subtotal excision Total excision Partial excision Total excision Follow-up 18 mo, norm dvpt, upper limb paralysis 14 mo, norm dvpt 3 y 6 mo, norm dvpt, dysphasia 24 mo norm dvpt 13 mo death 7 y, norm dvpt
Note.—Yes (Y), no (N), normal development (norm dvpt).